Viewing Study NCT06236061


Ignite Creation Date: 2025-12-24 @ 12:19 PM
Ignite Modification Date: 2025-12-27 @ 9:16 PM
Study NCT ID: NCT06236061
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2024-01-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module